BrainsWay
Biotechnology, Health Care · 129 employees
BrainsWay is a global leader in advanced noninvasive neurostimulation treatments for mental health disorders. The Company is boldly advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS™) platform technology to improve health and transform lives.
Funding history
- Funding Round — $20.0M — Oct 2024
Recent signals
- Oct 15, 2024: Raised $20.0M
- Sep 30, 2024: BrainsWay Announces US$20 Million Partnership with Valor Equity Partners
- Aug 29, 2024: BrainsWay Appoints Richard A. Bermudes, M.D. as Chief Medical Officer
See plans & pricing → Track BrainsWay’s funding, hiring, and signals — with verified contacts — on Fundz.